This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1983.
Company Filing History:
Years Active: 1983
Title: John P. Tengi: Innovator in Beta-Lactamase Inhibitors
Introduction
John P. Tengi is a notable inventor based in Cedar Grove, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactamase inhibitors. His work has implications for enhancing the efficacy of certain antibiotics, which is crucial in the fight against antibiotic resistance.
Latest Patents
Tengi holds a patent for a beta-lactamase inhibitor, which is described as a compound that inhibits the activity of enzymes responsible for inactivating specific beta-lactam antibiotics. The patent details the formula and the pharmaceutically acceptable salts of the compound, along with the intermediates and synthetic processes for its manufacture. This innovation is vital for improving the effectiveness of antibiotics in medical treatments.
Career Highlights
John P. Tengi is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this organization has allowed him to focus on groundbreaking research and development in the field of antibiotic resistance.
Collaborations
Throughout his career, Tengi has collaborated with esteemed colleagues such as Dennis D. Keith and Manfred Weigele. These partnerships have fostered an environment of innovation and have contributed to the advancement of pharmaceutical research.
Conclusion
John P. Tengi's contributions to the field of beta-lactamase inhibitors highlight his role as an important inventor in the pharmaceutical industry. His work not only advances scientific knowledge but also has practical applications in improving antibiotic treatments.